brightfield

AI-powered tools that quantify tumor content and guide ROI selection to enhance macrodissection workflows and downstream molecular analysis.

An automated, AI-based decision-support tool that standardizes scoring of HER2, ER, PR, and Ki67 IHC in breast cancer cases.

An automated, AI-based decision-support tool that standardizes the scoring of PD-L1 IHC in NSCLC cases.

An automated, AI-based tool for quality control of whole slide H&E- and IHC-stained images.

A CE-IVD certified deep learning-based screening tool for prostate cancer.